Virtual Incision Receives Investigational Device Exemption (IDE) to Initiate Study of First-of-its-Kind MIRA Platform

Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery HOLLAND, Mich., Oct. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Genesis Innovation Group's cultivate(MD) Capital Fund II LP, a fund focused on investments into ea... Devices, Surgery, FDA Genesis Innovation Group, Virtual Incision, MIRA Surgical Platform
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news